A research letter in JAMA Internal Medicine discusses physicians perspectives on FDA expedited drug approval pathways.
Read More
A research letter in JAMA Internal Medicine describes consumer reactions to drug pricing disclosure.
Read More
A report from PriceWaterhouse Cooper evaluates the year that was in health care M & A.
Read More
A report from IQVIA covers expected spending and trends in global drug use over the next few years.
Read More
Rising drug prices are contributing to hospitals' increased costs of delivering care.
Read More
More bad news for the hospital readmission reduction program, as a new study in Health Affairs concludes that it had far less effect than previously estimated.
Read More
The annual ECRI Institute list of health safety hazards is out.
Read More
A McKinsey post addresses issues around patient adherence to treatment regimens.
Read More
A study in Health Affairs finds that "digital" health companies provide little value for the populations that likely need the most help.
Read More
An evaluation of the first two years of the mandatory joint replacement episode payment program in Medicare found minor spending reductions and no effect on quality.
Read More
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at khroche@healthy-skeptic.com.